EMEA-000196-PIP01-08-M04
Key facts
| Invented name |
Incivo
|
| Active substance |
telaprevir
|
| Therapeutic area |
Infectious diseases
|
| Decision number |
P/0093/2017
|
| PIP number |
EMEA-000196-PIP01-08-M04
|
| Pharmaceutical form(s) |
|
| Condition(s) / indication(s) |
Treatment of chronic hepatitis C
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Janssen-Cilag International NV
E-mail: contact@janssen-emea.com |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|